
Mohan Babulal Jain
About Mohan Babulal Jain
Data last updated:
Mohan Babulal Jain is a Director at Naprod Life Sciences Private Limited (since 1994), Director at Mac-Chem Products (India) Private Limited (since 2007) and Managing Director at Samrudh Pharmaceuticals Private Limited (since 2018), and holds 3 more current directorships. The companies operate in Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹540 Cr; the largest is Naprod Life Sciences Private Limited at ₹220 Cr (FY 2025). Earlier, Mohan Babulal Jain was a Director at Naprod Pharmaceutical Private Limited (from 2007).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Mar 1994 | 1990 | ₹220 Cr (FY 2025) | Active | |
| Director | 05 Feb 2007 | 1991 | ₹168 Cr (FY 2025) | Active | |
| Managing Director | 26 Mar 2018 | 1991 | ₹101 Cr (FY 2025) | Active | |
| Director | 12 Jun 2019 | 2019 | ₹39.34 Cr (FY 2025) | Active | |
| Director | 22 May 2007 | 2007 | ₹12.12 Cr (FY 2025) | Active | |
| Designated Partner | 26 May 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Feb 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mohan Babulal Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aarya Mohan Jain | 11000730 | Naprod Life Sciences Private Limited , Mac-Chem Products (India) Private Limited and 3 more | Director |
| Manish Babulal Jain | 01538004 | Naprod Life Sciences Private Limited , Mac-Chem Products (India) Private Limited and 4 more | Director |
| Alok Sharad Sheth | 01330043 | Samrudh Pharmaceuticals Private Limited | Whole-Time Director |
| Sharad Himatlal Sheth | 01742585 | Samrudh Pharmaceuticals Private Limited | Whole-Time Director |
| Hiten Patel | 01212873 | Vanquest Pharma Private Limited | Director |
| Pavan H Patel | 03439561 | Vanquest Pharma Private Limited | Director |
| Pratik Hitenkumar Patel | 03369116 | Vanquest Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohan Babulal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohan Babulal Jain
Mohan Babulal Jain currently holds 6 directorships: Naprod Life Sciences Private Limited (Director, since 02 Mar 1994, revenue ₹220 Cr (FY 2025)); Mac-Chem Products (India) Private Limited (Director, since 05 Feb 2007, revenue ₹168 Cr (FY 2025)); Samrudh Pharmaceuticals Private Limited (Managing Director, since 26 Mar 2018, revenue ₹101 Cr (FY 2025)); Vanquest Pharma Private Limited (Director, since 12 Jun 2019, revenue ₹39.34 Cr (FY 2025)); Miracalus Pharma Private Limited (Director, since 22 May 2007, revenue ₹12.12 Cr (FY 2025)); and 1 more.
Mohan Babulal Jain was first appointed on 02 Mar 1994 as Director at Naprod Life Sciences Private Limited. The most recent appointment on record is 12 Jun 2019 at Vanquest Pharma Private Limited.
The 5 current companies of Mohan Babulal Jain that report revenue have a combined latest revenue of ₹540 Cr: Naprod Life Sciences Private Limited ₹220 Cr (FY 2025); Mac-Chem Products (India) Private Limited ₹168 Cr (FY 2025); Samrudh Pharmaceuticals Private Limited ₹101 Cr (FY 2025); Vanquest Pharma Private Limited ₹39.34 Cr (FY 2025); Miracalus Pharma Private Limited ₹12.12 Cr (FY 2025).
Mohan Babulal Jain held 1 earlier board appointment: Naprod Pharmaceutical Private Limited (Director, from 16 Feb 2007).
The current boards of Mohan Babulal Jain's companies include Aarya Mohan Jain (Naprod Life Sciences Private Limited), Manish Babulal Jain (Naprod Life Sciences Private Limited), Alok Sharad Sheth (Samrudh Pharmaceuticals Private Limited), Sharad Himatlal Sheth (Samrudh Pharmaceuticals Private Limited), Hiten Patel (Vanquest Pharma Private Limited), Pavan H Patel (Vanquest Pharma Private Limited), among others.